These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35747732)

  • 1. Mixed invasive fungal infections among COVID-19 patients.
    Singh V; Prasad A; Panda PK; Totaganti M; Tyagi AK; Thaduri A; Rao S; Bairwa M; Singh AK
    Curr Med Mycol; 2021 Dec; 7(4):19-27. PubMed ID: 35747732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19-Associated mucormycosis: Case series from a tertiary care hospital in South India.
    Rashbi K S; Ali TMF; P N D; C K S; Payyappilly RJ
    Access Microbiol; 2022 Aug; 4(6):acmi000360. PubMed ID: 36004359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive Mucormycosis and Aspergillosis Coinfection Associated with Post-COVID-19 Pneumonia in a Tertiary Care Hospital.
    Paul M; Sasidharan J; Taneja J; Chatterjee K; Abbas SZ; Chowdhury V; Das A
    Med Mycol J; 2022; 63(3):59-64. PubMed ID: 36047183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mixed invasive fungal infection due to Rhizomucor pusillus and Aspergillus niger in an immunocompetent patient].
    Pozo-Laderas JC; Pontes-Moreno A; Robles-Arista JC; Bautista-Rodriguez MD; Candau-Alvarez A; Caro-Cuenca MT; Linares-Sicilia MJ
    Rev Iberoam Micol; 2015; 32(1):46-50. PubMed ID: 23583263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case series of invasive lung infections by
    Mahajan M; Prasanna S; Das NK; Mahajan N
    J Family Med Prim Care; 2022 Nov; 11(11):7469-7475. PubMed ID: 36993027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fungal Invasive Co-Infection Due to
    Ramírez-Hinojosa JP; Medrano-Ahumada S; Arenas R; Bravo-Escobar A; Paraguirre-Martínez S; Xicohtencatl-Cortes J; Martínez-Herrera E; Hernández-Castro R
    J Fungi (Basel); 2021 Dec; 7(12):. PubMed ID: 34947078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological Study of Mucormycosis in COVID-19 Patients: Experience From a Tertiary Care Center in South India.
    Kandasamy S; Muthuraju S; Vasugi A; Chandrasekar M; Murugan R; Inbasekaran P; R P
    Cureus; 2022 Mar; 14(3):e23016. PubMed ID: 35419223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucormycosis and COVID-19 an epidemic in a pandemic?
    Banerjee I; Robinson J; Asim M; Sathian B; Banerjee I
    Nepal J Epidemiol; 2021 Jun; 11(2):1034-1039. PubMed ID: 34290893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utility of antifungal susceptibility testing in patients with fungal rhinosinusitis.
    Mammen MD; Sahni RD; Varghese GM; Rupa V
    Indian J Med Microbiol; 2021 Jul; 39(3):328-333. PubMed ID: 33906748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID19 associated mucormycosis: A review.
    Palanisamy PR; Elango D
    J Family Med Prim Care; 2022 Feb; 11(2):418-423. PubMed ID: 35360784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19-associated mixed mold infection: A case report of aspergillosis and mucormycosis and a literature review.
    Benhadid-Brahmi Y; Hamane S; Soyer B; Mebazaa A; Alanio A; Chousterman B; Bretagne S; Dellière S
    J Mycol Med; 2022 Mar; 32(1):101231. PubMed ID: 34864498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of COVID-19-Associated Invasive Fungal Infection.
    Shishido AA; Mathew M; Baddley JW
    Curr Fungal Infect Rep; 2022; 16(3):87-97. PubMed ID: 35846240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First report of COVID-19-associated rhino-orbito-cerebral mucormycosis in pediatric patients with type 1 diabetes mellitus.
    Diwakar J; Samaddar A; Konar SK; Bhat MD; Manuel E; Hb V; Bn N; Parveen A; Hajira SN; Srinivas D; S N
    J Mycol Med; 2021 Dec; 31(4):101203. PubMed ID: 34517273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Mystery of Mucormycosis in COVID-19: A Multifactorial Menace or an Enigmatic Delta Variant Associated Phenomenon? An Exploratory Study from a Tertiary Care Centre in North India with a Brief Literature Review.
    Kalita D; Bhatia M; Rekha US; Singh A
    J Pharm Bioallied Sci; 2022; 14(1):46-51. PubMed ID: 35784107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and outcomes of COVID associated mucormycosis in kidney transplant recipients.
    Bansal SB; Rana A; Babras M; Yadav D; Jha P; Jain M; Sethi SK
    Transpl Infect Dis; 2022 Apr; 24(2):e13777. PubMed ID: 34932870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19-Associated Mucormycosis in a Tertiary Care Hospital in India: A Case Series.
    Singh S; Basera P; Anand A; Ozair A
    Cureus; 2022 Aug; 14(8):e27906. PubMed ID: 36110469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of mucormycosis in COVID-19 patients in a tertiary care center, Raichur Institute of Medical Sciences, Raichur.
    Chemudugunta R; Bindu C; Indrani K; Ramesh BH
    J Oral Maxillofac Pathol; 2022; 26(4):593. PubMed ID: 37082037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 Associated Vertebral Osteomyelitis Caused by
    Prayag PS; Purandare BD; Patwardhan SA; Pairaiturkar PP; Rege AJ; Bhave AV; S R; Panchakshari SP; Raja PT; Melinkeri AS; Prayag AP
    Indian J Orthop; 2022 Jul; 56(7):1268-1276. PubMed ID: 35440826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary defense mechanisms against opportunistic fungal pathogens.
    Waldorf AR
    Immunol Ser; 1989; 47():243-71. PubMed ID: 2490078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case Report: COVID-19-associated Rhinosinusitis Mucormycosis Caused by Rhizopus arrhizus: A Rare but Potentially Fatal Infection Occurring After Treatment with Corticosteroids.
    Tabarsi P; Khalili N; Pourabdollah M; Sharifynia S; Safavi Naeini A; Ghorbani J; Mohamadnia A; Abtahian Z; Askari E
    Am J Trop Med Hyg; 2021 Jul; 105(2):449-453. PubMed ID: 34237015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.